Skip to main content

Find Clinical Trials

Home
Conditions
CTLA-4

Clinical trial condition

CTLA-4

Explore clinical trials studying CTLA-4. Study availability and eligibility vary by location and protocol.

3 public trials 0 recruiting studies

Refine in advanced search Browse all conditions

CTLA-4 trial results

Not Yet Recruiting

A Single-Arm, Multicenter, Exploratory Clinical Study of TACE Combined With Iparomlimab and Tuvonralimab Injection (QL1706) and Lenvatinib for Perioperative Treatment of Resectable Hepatocellular Carcinoma

NCT07131501

Conditions: Adenocarcinoma, CTLA-4, Carcinoma, +14 more
Locations: The First Affiliated Hospital with Nanjing Medical University Nanjing, Jiangsu, China

View Trial Details

Not Yet Recruiting

A Single-Arm, Multicenter, Exploratory Clinical Study of Transarterial Chemoembolization (TACE) Combined With Iparomlimab and Tuvonralimab Injection and Bevacizumab Injection for the Treatment of Unresectable, Non-Metastatic Hepatocellular Carcinoma (HCC)

NCT07128251

Conditions: Adenocarcinoma, CTLA-4, Carcinoma, +14 more
Locations: Not specified

View Trial Details

Not Yet Recruiting

Efficacy and Safety of Iparomlimab and Tuvonralimab Injection in Combination With Bevacizumab After Progression on Anti-PD-(L)1 Therapy in Advanced Melanoma: A Prospective, Single-Arm, Exploratory Clinical Study

NCT07004335

Conditions: Advanced Melanoma, Bevacizumab, CTLA-4, +4 more
Locations: The Fourth Hospital of Hebei Medical University Shijiazhuang, China

View Trial Details